Chapter 3 Mechanism of action-molecular effects

Comprehensive Series in Photosciences

Volumn 2, Issue C, 2001, Pages 39-54

  Moor, Anne C E ^a   Ortel, Bernhard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745047499     PISSN: 1568461X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1568-461X(01)80107-1     Document Type: Article

References (84)

1. Peng Q., Moan J., and Nesland J.M. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol. 20 (1996) 109-129
2. Moor A.C.E. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B. 57 (2000) 1-13
3. Oleinick N.L., and Evans H.H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150 (1998) S146-S156
4. Hamblin M.R., Miller J.L., and Ortel B. Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 72 (2000) 533-540
5. Hasan T. Photosensitizer delivery mediated by macromolecular carrier systems. In: Dougherty T.J., and Henderson B.W. (Eds). Photodynamic Therapy: Basic Principals and Clinical Applications (1992), Marcel Dekker, New York, NY 187-200
6. Coven T.R., Walters I.B., Cardinale I., and Krueger J.G. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed. 15 (1999) 22-27
7. Murphy F.P., Coven T.R., Burack L.H., Gilleaudeau P., Cardinale I., Auerbach R., and Krueger J.G. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes. Arch. Dermatol. 135 (1999) 1495-1502
8. Granville D.J., Carthy C.M., Jiang H., Shore G.C., McManus B.M., and Hunt D.W. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cell treated with photodynamic therapy. FEBS Lett. 43 7 (1998) 5-10
9. Kessel D., and Luo Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ. 6 (1999) 28-35
10. Varnes M.E., Chiu S.M., Xue L.Y., and Oleinick N.L. Photodynamic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. Biochem. Biophys. Res. Commun. 255 (1999) 673-679
11. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
12. Nunez G., Benedict M.A., Hu Y., and Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene 17 (1998) 3237-3245
13. Porter A.G., and Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6 (1999) 99-104
14. Luo Y., and Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem. Photobiol. 66 (1997) 479-483
15. He J., Whitacre C.M., Xue L.Y., Berger N.A., and Oleinick N.L. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. Cancer Res. 58 (1998) 940-946
16. Granville D.J., Levy J.G., and Hunt D.W. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Diff. 4 (1997) 623-629
17. Granville D.J., Shaw J.R., Leong S., Carthy C.M., Margaron P., Hunt D.W., and McManus B. Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apopotosis. Am. J. Pathol. 155 (1999) 1021-1025
18. Zhuang S., Lynch M.C., and Kochevar I.E. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Exp. Cell Res. 250 (1999) 203-212
19. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., and Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53 (1993) 4701-4714
20. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
21. Granville D.J., Jiang H., An M.T., Levy J.G., McManus B.M., and Hunt D.W. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy. Br. J. Cancer 79 (1999) 95-100
22. He J., Agarwal M.L., Larkin H.E., Friedman L.R., Xue L.Y., and Oleinick N.L. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochem. Photobiol. 64 (1996) 845-852
23. Zhang W.G., Ma L.P., Wang S.W., Zhang Z.Y., and Cao G.D. Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy. Photochem. Photobiol. 69 (1999) 582-586
24. Payne C.M., Bernstein C., and Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk. Lymphoma. 19 (1995) 43-93
25. Ben-Hur E., and Dubbelman T.M. Cytoplasmic free calcium changes as a trigger mechanism in the response of cells to photosensitization. Photochem. Photobiol. 58 (1993) 890-894
26. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
27. Kluck R.M., Bossy-Wetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
28. Carthy C.M., Granville D.J., Jiang H., Levy J.G., Rudin C.M., Thompson C.B., McManus B.M., and Hunt D.W. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab. Invest. 79 (1999) 953-965
29. Kim H.R., Luo Y., Li G., and Kessel D. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res. 59 (1999) 3429-3432
30. Agarwal M.L., Larkin H.E., Zaidi S.I., Mukhtar H., and Oleinick N.L. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res. 535 (1993) 897-5902
31. Penning L.C., Rasch M.H., Ben-Hur E., Dubbelman T.M., Havelaar A.C., Van der Zee J., and Van Steveninck J. A role for the transient increase of cytoplasmic free calcium in cell rescue after photodynamic treatment. Biochim. Biophys. Acta. 1107 (1992) 255-260
32. Penning L.C., Keirse M.J., VanSteveninck J., and Dubbelman T.M. Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. Biochem. J. 292 (1993) 237-240
33. Penning L.C., VanSteveninck J., and Dubbelman T.M. HPD-induced photodynamic changes in intracellular cyclic AMP levels in human bladder transitional carcinoma cells, clone T24. Biochem. Biophys. Res. Commun. 194 (1993) 1084-1089
34. Rasch M.H., Tijssen K., Lagerberg J.W., Corver W.E., VanSteveninck J., and Dubbelman T.M. The role of protein kinase C activity in the killing of Chinese hamster ovary cells by ionizing radiation and photodynamic treatment. Photochem. Photobiol. 66 (1997) 209-213
35. Zhuang S., Lynch M.C., and Kochevar I.E. Activation of protein kinase C is required for protection of cells against apoptosis induced by singlet oxygen. FEBS Lett. 437 (1998) 158-162
36. Luo Y., and Kessel D. The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy. Biochem. Biophys. Res. Commun. 221 (1996) 72-76
37. Berg K., and Moan J. Lysosomes and microtubules as target for photochemotherapy of cancer. Photochem. Photobiol. 65 (1997) 403-409
38. Hofmann K., and Dixit V.M. Ceramide in apoptosis-does it really matter?. Trends Biochem. Sci. 23 (1998) 374-377
39. Separovic D., He J., and Oleinick N.L. Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells. Cancer Res. 57 (1997) 1717-1721
40. Separovic D., Mann K.J., and Oleinick N.L. Association of ceramide accumulation with photodynamic treatment-induced cell death. Photochem. Photobiol. 68 (1998) 101-109
41. Separovic D., Pink J.J., Oleinick N.A., Kester M., Boothman D.A., McLoughlin M., Pena L.A., and Haimovitz-Friedman A. Niemann-Pick human lymphoblasts are resistant to phthalocyanine 4-photodynamic therapy-induced apoptosis. Biochem. Biophys. Res. Commun. 258 (1999) 506-512
42. Fisher A.M., Ferrario A., Rucker N., Zhang S., and Gomer C.J. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer Res. 59 (1999) 331-335
43. Ahmad N., Feyes D.K., Agarwal R., and Mukhtar H. Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. Proc. Natl. Acad. Sci. USA 95 (1998) 6977-6982
44. Gupta S., Ahmad N., and Mukhtar H. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res. 58 (1998) 1785-1788
45. Ahmad N., Gupta S., and Mukhtar H. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Oncogene 18 (1999) 1891-1896
46. Kalka K., Ahmad N., Kermode T., and Mukhtar H. Involvement of epidermal growth factor receptor (EGF-R)-tyrosine kinase pathway in photodynamic therapy-mediated cell death. J. Invest. Dermatol. 112 (1999) 659
47. Klotz L.O., Fritsch C., Briviba K., Tsacmacidis N., Schliess F., and Sies H. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Res. 58 (1998) 4297-4300
48. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., and Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 260 (1999) 917-922
49. Tao J., Sanghera J.S., Pelech S.L., Wong G., and Levy J.G. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem. 271 (1996) 27107-27115
50. Xue L., He J., and Oleinick N.L. Promotion of photodynamic therapy-induced apoptosis by stress kinases. Cell Death Diff. 6 (1999) 855-864
51. Assefa Z., Vantieghem A., Declercq W., Vandenabeele P., Vandenheede J.R., Merlevede W., de Witte P., and Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 274 (1999) 8788-8796
52. Verheij M., Ruiter G.A., Zerp S.F., van Blitterswijk W.J., Fuks Z., Haimovitz-Friedman A., and Bartelink H. The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. Radiother. Oncol. 47 (1998) 225-232
53. Srivastava R.K., Mi Q.S., Hardwick J.M., and Longo D.L. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. USA 96 (1999) 3775-3780
54. Xue L.Y., He J., and Oleinick N.L. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4. Photochem. Photobiol. 66 (1997) 105-113
55. Curry P.M., and Levy J.G. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative. Photochem. Photobiol. 58 (1993) 374-379
56. Gomer C.J., Ryter S.W., Ferrario A., Rucker N., Wong S., and Fisher A.M. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res. 56 (1996) 2355-2360
57. Xue L.Y., Agarwal M.L., and Varnes M.E. Elevation of GRP-78 and loss of HSP-70 following photodynamic treatment of V79 cells: sensitization by nigericin. Photochem. Photobiol. 62 (1995) 135-143
58. Luna M.C., Ferrario A., Wong S., Fisher A.M., and Gomer C.J. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res. 60 (2000) 1637-1644
59. 2+ disturbances, and cell death in renal epithelial cells. J. Biol. Chem. 272 (1997) 21751-21759
60. Gomer C.J., Ferrario A., Rucker N., Wong S., and Lee A.S. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res. 51 (1991) 6574-6579
61. Morgan J., Whitaker J.E., and Oseroff A.R. GRP78 induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye victoria blue BO. Photochem. Photobiol. 67 (1998) 155-164
62. Gomer C.J., Luna M., Ferrario A., and Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem. Photobiol. 53 (1991) 275-279
63. Bressoud D., Jomini V., and Tyrrell R.M. Dark induction of haem oxygenase messenger RNA by haematoporphyrin derivative and zinc phthalocyanine; agents for photodynamic therapy. J. Photochem. Photobiol. B. 14 (1992) 311-318
64. Gollnick S.O., Liu X., Owczarczak B., Musser D.A., and Henderson B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57 (1997) 3904-3909
65. Scholzen T., Hartmeyer M., Fastrich M., Brzoska T., Becher E., Schwarz T., and Luger T.A. Ultraviolet light and interleukin-10 modulate expression of cytokines by transformed human dermal microvascular endothelial cells (HMEC-1). J. Invest. Dermatol. 111 (1998) 50-56
66. Kulms D., Poppelmann B., and Schwarz T. Ultraviolet radiation-induced interleukin 6 release in HeLa cells is mediated via membrane events in a DNA damage-independent way. J. Biol. Chem. 275 (2000) 15060-15066
67. Simkin G.O., Tao J.S., Levy J.G., and Hunt D.W. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J. Immunol. 164 (2000) 2457-2462
68. Kick G., Messer G., Goetz A., Plewig G., and Kind P. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res. 55 (1995) 2373-2379
69. Kick G., Messer G., Plewig G., Kind P., and Goetz A.E. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br. J. Cancer 74 (1996) 30-36
70. Legrand-Poels S., Schoonbroodt S., Matroule J.Y., and Piette J. Nf-kappa B: an important transcription factor in photobiology. J. Photochem. Photobiol. B. 45 (1998) 1-8
71. Piret B., Legrand-Poels S., Sappey C., and Piette J. NF-kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization. Eur. J. Biochem. 228 (1995) 447-455
72. Ryter S.W., and Gomer C.J. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem. Photobiol. 58 (1993) 753-756
73. Legrand-Poels S., Zecchinon L., Piret B., Schoonbroodt S., and Piette J. Involvement of different transduction pathways in NF-kappa B activation by several inducers. Free Radic. Res. 27 (1997) 301-309
74. Matroule J.Y., Bonizzi G., Morliere P., Paillous N., Santus R., Bours V., and Piette J. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kapaB through the interleukin-1 recepto-dependent signaling pathway. J. Biol. Chem. 274 (1999) 2988-3000
75. Abeyama K., Eng W., Jester J.V., Vink A.A., Edelbaum D., Cockerell C.J., Bergstresser P.R., and Takashima A. A role for NF-kappaB-dependent gene transactivation in sunburn. J. Clin. Invest. 105 (2000) 1751-1759
76. Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39 (2000) 103-111
77. Drillenburg P., and Pals S.T. Cell adhesion receptors in lymphoma dissemination. Blood 95 (2000) 1900-1910
78. Johnson J.P. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis. Rev. 18 (1999) 345-357
79. King D.E., Jiang H., Simkin G.O., Obochi M.O., Levy J.G., and Hunt D.W. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand. J. Immunol. 49 (1999) 184-192
80. Runnels J.M., Chen N., Ortel B., Kato D., and Hasan T. BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and betal integrin expression in ovarian cancer cells. Br. J. Cancer. 80 (1999) 946-953
81. Rousset N., Vonarx V., Eléouet S., Carré J., Kerninon E., Layat Y., and Patrice T. Effects of photodynamic therapy on adhesion molecules and metastasis. J. Photochem. Photobiol. B: Biol. 52 (1999) 65-73
82. Margaron P., Sorrenti R., and Levy J.G. Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochim. Biophys. Acta 1359 (1997) 200-210
83. Hunt D.W., Jiang H., Granville D.J., Chan A.H., Leong S., and Levy J.G. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 41 (1999) 31-44
84. Blom D.J., Schuitmaker H.J., de Waard-Siebinga I., Dubbelman T.M., and Jager M.J. Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy. Cancer Lett. 112 (1997) 239-243